| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2000;18:524-528
© 2000 Elsevier Science NL
Service de Chirurgie Thoracique, Hôpitaux Universitaires de Strasbourg, F-67091 Strasbourg, France
Received 5 May 2000; received in revised form 11 August 2000; accepted 5 September 2000.
Corresponding author. Tel.:+33-3-8811-6202; fax: +33-3-8811-6077
e-mail: gilbert.massard{at}chru-strasbourg.fr
Objective: Having demonstrated a poor prognosis of operable lung cancer in patients with previous head and neck malignancies, we intended to evaluate prognosis of lung cancer in patients with a history of extrapulmonary and extracervical malignancies. Methods: The population of this study included 55 patients; these were 40 males and 15 females, with a mean age 64.4±8.6 years. The previous malignancy was considered tobacco-induced in 15 patients (kidney, two; bladder, ten; esophagus, three), hormone-dependant in 18 (breast, six; female genital, eight; prostate, four), and miscellaneous in 22 (leukemia, four; skin, seven; colon, 11). Following complete resection, 25 patients were classified stage I, 13 were stage II, and 17 were stage IIIA. Results: There were two early perioperative deaths (3.6%), and three during the second month owing to cardiovascular complications. At the conclusion of the study (July 1st, 1997), 32 further patients had died (58.2%): 25 had progression of lung cancer, one had progression of previous malignancy, and six were without evidence of disease. Five-year survival (Kaplan–Meier) was estimated 47±10.2% in stage I (median 44 months), 30.8±15.6% in stage II (median 26 months), and 16.7±9.9% in stage IIIA (median 17 months). When excluding five early perioperative deaths, 5-year survival was 51.1±10.6% in stage I (median 93 months), 33.3±16.7% in stage II (median 36.5 months), and 19.0±11.2% in stage IIIA (median 20.5 months). Comparing the three groups defined according to location of previous malignancy, there was no significant difference neither in stage distribution (
2=1.326; P=0.857), nor in 5-year survival estimates: 38.9±12.9% (median 27 months) after tobacco-induced malignancies, 38.9±11.5% (median 24 months) following hormone-dependant malignancies, and 28.4±10.2% (median 28 months) following miscellaneous cancers (2=0.059; P=0.9707). Conclusions: In opposition to data collected in patients with previous head and neck cancer, survival estimates according to stage were contained within the universally accepted range no high risk group has been identified. Resection of lung cancer with curative intent is a fair option in patients with previous extrapulmonary malignancy.
Key Words: Multiple cancers • Bronchogenic cancer • Surgery
This article has been cited by other articles:
|
|
 |
|
  R. Aguilo, F. Macia, M. Porta, M. Casamitjana, J. Minguella, and A. M. Novoa Multiple independent primary cancers do not adversely affect survival of the lung cancer patient Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 1075 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Thomas, C. Doddoli, X. Thirion, O. Ghez, M.-J. Payan-Defais, R. Giudicelli, and P. Fuentes Stage I non-small cell lung cancer: a pragmatic approach to prognosis after complete resection Ann. Thorac. Surg., April 1, 2002; 73(4): 1065 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Doddoli, P. Thomas, O. Ghez, R. Giudicelli, and P. Fuentes Surgical management of metachronous bronchial carcinoma Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 899 - 903. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
